内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Sarena Francis Willard. Director active across 3 companies, notably Apexigen, Inc.. Aggregated, 21 disclosures have been logged. Split: 0 buy · 6 sells. History available since 7 October 2022. The latest transaction was disclosed on 1 August 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sarena Francis Willard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
75,310 股Common StockSEC:0001193125-25-259037:0
3,206 股@ US$9.1650.8% 占其流量Common StockSEC:0000950170-25-103380:0
2,979 股@ US$9.6949.2% 占其流量Common StockSEC:0000950170-25-103380:1
53,750 股0Common StockSEC:0000950170-25-014077:0
25,000 股0Common StockSEC:0000950170-24-093069:0
31,123 股@ US$0.385152.5% 占其流量Common StockSEC:0001209191-23-047439:0
6,917 股@ US$0.491114.8% 占其流量Common StockSEC:0001209191-23-039495:0
150,000 股0Common StockSEC:0001209191-23-032162:0
6,916 股@ US$1.0632.7% 占其流量Common StockSEC:0001209191-22-062004:0
40,000 股0Common StockSEC:0001209191-22-053349:0
9,479 股Common StockSEC:0001123292-16-001659:0
6,895 股Common StockSEC:0001123292-16-001659:1
2,584 股Common StockSEC:0001123292-16-001659:2
3,791 股Common StockSEC:0001123292-16-001659:3
3,791 股Common StockSEC:0001123292-16-001659:4
7,449 股Common StockSEC:0001123292-16-001659:5
7,449 股Common StockSEC:0001123292-16-001659:6
7,768 股Common StockSEC:0001123292-16-001659:7
7,768 股Common StockSEC:0001123292-16-001659:8
1,513 股Common StockSEC:0001123292-16-001659:9
1,513 股Common StockSEC:0001123292-16-001659:10
About Sarena Francis Willard
Sarena Francis Willard is a declarant linked to FIVE PRIME THERAPEUTICS INC, 89bio, Inc., and Apexigen, Inc., with 21 filings in total. In the recent filings available, the transactions are disposals, over the period from 2016-01-29 to 2025-10-30, with reported sell volume of EUR 0.